Skip to main content

News & Announcements


Senescent brain cells may contribute to Alzheimer’s disease


Blood marker shows potential for tracking frontotemporal dementia


Virtual workshop: Modeling basic mechanisms of brain aging and Alzheimer’s disease in vitro and in silico


Two molecular maps of blood vessels in the human brain reveal links to dementia


TREM2 protein seems to protect brain cells from toxic TDP-43 protein


Blocking hormone improves Alzheimer’s symptoms in mice


Aging disrupts the normal daily fluctuations of immune cell activity


Join the 2022 Alzheimer’s Disease-Related Dementias Summit


Imaging technique shows Alzheimer’s impact on brain connections


Inside the brain: The role of neuropathology in Alzheimer’s disease research


Workshop: Can Autism Spectrum Disorders Tell Us Anything About Alzheimer’s Disease?


APOE ε4 is not associated with increased risk for Alzheimer’s disease and dementia in American Indians


Scientists discover a new molecular pathway shared by two neurodegenerative disorders


Blood test can predict presence of beta-amyloid in the brain, new study finds


High blood pressure may lower or raise dementia risk among older adults depending on age


Cataract removal linked to a reduction in dementia risk


Study maps out genomic regions that may control levels of proteins linked to neurological disorders


Viagra associated with reduced risk of Alzheimer’s disease


Immune system may play harmful role in Lewy body dementia


Changes in a small area in the brainstem could help detect Alzheimer’s disease earlier


Ritalin reduced apathy in NIA-funded Alzheimer’s clinical trial


NIA-VA effort increases recruitment of veterans for Alzheimer’s research


Sex-specific differences in aging and Alzheimer’s disease may be tied to genetics


Mini-brain model of frontotemporal dementia demonstrates the stages of dysfunction that lead to cell death


A new strategy for Alzheimer’s disease treatment targets cell-wide protein malfunction